Montage Resources Corp
Change company Symbol lookup
Select an option...
MR Montage Resources Corp
AMAG AMAG Pharmaceuticals Inc
HCI Hci Group Inc
PSF Cohen & Steers Select Preferred and Income Fund
PJT PJT Partners Inc
ALK Alaska Air Group Inc
RS Reliance Steel & Aluminum Co
HFWA Heritage Financial Corp
MET MetLife Inc
KALU Kaiser Aluminum Corp
Go

Energy : Oil, Gas & Consumable Fuels | Small Cap Value
Company profile

Montage Resources Corp, formerly Eclipse Resources Corp, is an independent exploration and production company. The Company is engaged in the acquisition and development of oil and natural gas properties in the Appalachian Basin. It is the operator of the Utica Core Area and its Marcellus Project Area. The Ordovician-aged Utica Shale is an unconventional reservoir consisting of organic-rich black shale, with production occurring at vertical depths between 6,000 and 10,000 feet. The Marcellus Shale consists of organic-rich black shale, with production occurring at vertical depths between 5,000 and 8,000 feet. As of December 31, 2016, it had approximately 92,000 net acres in the Utica Shale in Eastern Ohio within the Utica Core Area. As of December 31, 2016, the Company had assembled an acreage position approximating 199,000 net acres in Eastern Ohio.

Closing Price
$5.78
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.96
Day's Low
5.67
Volume
(Above Average)
Volume:
499,161

10-day average volume:
430,428
499,161

ExceleraRx Corp.'s Holt and Schell to Present at InformaConnect IDN BioPharma Summit 2020

6:00 am ET October 1, 2020 (PR Newswire) Print

Excelera(R), the company behind the Excelera Network, announced today that Meredith Holt, National Vice President of Health System Partnerships will present at the IDN BioPharma Summit 2020, which is being held virtually on Monday, October 5 -8, 2020. Holt is one of four panelists including: Kim Coppom - Executive Director, US Managed Markets, Relypsa; Richard Demers - Chief Administrative Officer Ambulatory Pharmacy Services, University of Pennsylvania Health System; Jacob Jolly - Principle Consultant, Blue Fin Group; and Gerard Taglianetti - Market Access, Strategy & Analytics, Pfizer Inc.

https://mma.prnewswire.com/media/718462/ExceleraRx_Logo.jpg

The panel is billed as a Stakeholder Spotlight Session and is entitled "Best Practices from IDNs and Manufacturers -- Overall Strategies from Contracting to Operating". During this discussion, panelists from various healthcare industry stakeholders will answer questions collected from the pre-conference survey as well as in-room Q&A, help attendees recognize key take-aways for their unique situation and how to model your operation for success, and examine different types of risk share agreements, and discern the benefits of outcomes based contracting and value-based outcomes.

Dr. Schell is leading a live session on "New Ways of Thinking About Patient Outcomes" on Wednesday, Oct 7, 2020, which is focused on how to define value as the industry shifts toward value-based care. During the session, Dr. Schell will illustrate a model we have built for use across our nationwide network of health systems to help Excelera Network members help predict inactivity which could lead to non-adherence in patients with breast cancer. In addition, the discussion will highlight the use of demographics such as zip code, gender, age and other Social Determinants of Health (SDoH) to illustrate value in an integrated health system, and crowd-source via audience interaction additional and novel ways of thinking about patient outcomes.

For more information about the IDN BioPharma Summit 2020: https://informaconnect.com/idn-biopharma-partnering/agenda/1/

To learn more about how Excelera collaborates with health systems, pharma manufacturers, biopharma and life sciences, contact us here.

About Excelera(R) The Excelera(R) Network is comprised of integrated delivery networks, health systems, and large academic medical centers with a deep commitment to caring for complex patients. Through national-scale collaboration, the network more efficiently gains access to limited distribution drugs, utilizes tools, technology, and best practices to deliver high quality care.

ExceleraRx Corp. is a healthcare company that empowers integrated delivery networks, health systems, and large academic medical centers to provide integrated care for complex patients, leading to improved health outcomes and decreased healthcare costs. To learn more, visit http://www.excelerarx.com or follow us on LinkedIn.

https://c212.net/c/img/favicon.png?sn=CG43641&sd=2020-10-01

View original content to download multimedia:http://www.prnewswire.com/news-releases/excelerarx-corps-holt-and-schell-to-present-at-informaconnect-idn-biopharma-summit-2020-301143476.html

SOURCE ExceleraRx Corp.

https://rt.prnewswire.com/rt.gif?NewsItemId=CG43641&Transmission_Id=202010010600PR_NEWS_USPR_____CG43641&DateId=20201001

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.